News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Conference News ADA 2023 Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1 Shelley Wood June 29, 2023
News Daily News Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression L.A. McKeown February 17, 2023
News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT Michael O'Riordan November 05, 2022
News Conference News SCCT 2019 Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology Yael L. Maxwell July 15, 2019
News Daily News Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery Yael L. Maxwell January 09, 2018
News Daily News How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues Leah Lawrence August 01, 2017
News Daily News High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease Todd Neale August 17, 2015
News Conference News AHA 2012 EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES Jason Kahn November 04, 2012